Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v4-FR Version v4-FR
Language French French
Date Updated 2018-10-19 2018-10-19
Drug Identification Number 02274566 02274566
Brand name GD-AZITHROMYCIN GD-AZITHROMYCIN
Common or Proper name AZITHROMYCIN AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC GENMED A DIVISION OF PFIZER CANADA ULC
Ingredients AZITHROMYCIN AZITHROMYCIN
Strength(s) 100MG 100MG
Dosage form(s) POWDER FOR SUSPENSION POWDER FOR SUSPENSION
Route of administration ORAL ORAL
Packaging size 1 Bottle (300MG/15ML) 1 Bottle (300MG/15ML)
ATC code J01FA J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2019-11-30 2019-11-30
Actual discontinuation date
Remaining supply date 2019-11-30 2019-11-30
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments